Inhibrx Biosciences INBX
NASDAQ INBX
$90.59 -0.02 (-0.02%)
At close: Nov 11, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Return on Assets [ROA] (2024 - 2026)

Updated

Inhibrx Biosciences (INBX) recorded Return on Assets [ROA] of -88.72% in Q2 2026, down 16.73 percentage points from -71.99% a year earlier.

Analysis

Inhibrx Biosciences (INBX) Return on Assets [ROA] (2024 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences reported Return on Assets [ROA] of -85.60%, down 776.29 percentage points from FY2024.

  • Across earlier years, Return on Assets [ROA] came in at 690.69% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn - -81.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.72%
Mar 31, 2026 -78.79%
Dec 31, 2025 -86.47%
Sep 30, 2025 -79.62%
Jun 30, 2025 -71.99%
Mar 31, 2025 813.86%
Dec 31, 2024 836.82%
Sep 30, 2024 683.38%
API Access

Inhibrx Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INBX&period=max&api_key=YOUR_API_KEY